Preoperative Embolization in Surgical Treatment of Spinal Metastases.

February 25, 2014 updated by: Caroline Clausen, Rigshospitalet, Denmark

Preoperative Embolization in Surgical Treatment of Spinal Metastases. A Randomized Controlled Trial.

The main purpose of this study is to assess the efficacy of preoperative embolization in decreasing operative blood loss, decreasing the need for intraoperative transfusion and facilitate surgical resection in metastatic spine surgery. Furthermore the study aims at describing the vascularity in a series of spinal metastasis, and to correlate this with perioperative blood loss.

Study Overview

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen, Denmark, 2100
        • Department of Radiology, Rigshospitalet

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients scheduled for decompression and posterior thoracic and/or lumbar instrumented spinal fusion because of spinal metastasis/metastases.
  • Informed signed consent.

Exclusion Criteria:

  • Contrast fluid allergy.
  • Clotting disorders.
  • Renal failure.
  • Not suitable for arterial access.
  • Pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Preoperative embolization
32 patients with spinal metastasis/metastases will undergo arteriography and receive transcatheter arterial embolization of spinal metastasis/metastases 0-48 hours prior to surgery.
Arteriography and transcatheter arterial embolization of spinal metastasis/metastases 0-48 hours prior to surgery.
Other Names:
  • Therapeutic angiography
  • Transcatheter arterial embolization
  • Embolization
  • Selective arterial embolization
ACTIVE_COMPARATOR: Control group
32 patients with spinal metastasis/metastases will undergo arteriography of spinal metastasis/metastases without receiving transcatheter arterial embolization prior to surgery.
Arteriography of spinal metastasis/metastases without transcatheter arterial embolization prior to surgery.
Other Names:
  • Angiography

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Perioperative blood loss
Time Frame: Measured intraoperatively and 24 hours postoperatively.
Measured intraoperatively and 24 hours postoperatively.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perioperative blood transfusion volume
Time Frame: Intraoperatively and until 48 hours postoperatively.
Intraoperatively and until 48 hours postoperatively.
Surgical procedure time.
Time Frame: At skin closure.
Defined as the amount of time (measured in minutes) from skin incision to skin closure.
At skin closure.
Vascularization grade of metastasis
Time Frame: At the angiographic procedure prior to embolization performed 0-48 hours before surgery.
At the angiographic procedure prior to embolization performed 0-48 hours before surgery.
Success of embolization
Time Frame: Directly after the embolization performed 0-48 hours before surgery.
Directly after the embolization performed 0-48 hours before surgery.
Adverse events related to angiography or embolization
Time Frame: Within 2 postoperative days
Within 2 postoperative days
Adverse events related to surgery
Time Frame: Within 2 postoperative days
Within 2 postoperative days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Lars Lönn, MD, Ph.d., Department of Radiology, Rigshospitalet. Copenhagen, Denmark.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2011

Primary Completion (ACTUAL)

February 1, 2014

Study Completion (ACTUAL)

February 1, 2014

Study Registration Dates

First Submitted

May 27, 2011

First Submitted That Met QC Criteria

June 1, 2011

First Posted (ESTIMATE)

June 3, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

February 26, 2014

Last Update Submitted That Met QC Criteria

February 25, 2014

Last Verified

February 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • H-2-2011-024 (OTHER: The Danish Committee on Biomedical Research Ethics)
  • 2008-41-2128 (OTHER: Danish Dataprotection Agency)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Metastases

Clinical Trials on Arteriography and preoperative embolization

Subscribe